Quidel | QDEL - Current Liabilities


Quidel reported $993.4M in Current Liabilities for its fiscal quarter ending in June of 2026.





Current Liabilities Change Date
Abbott USD 18.38B 1.88B Mar/2026
Agilent USD 2.27B 35M Mar/2026
Becton, Dickinson and Co. USD 9.4B 897M Jun/2026
Bruker USD 1.2B 150.4M Jun/2026
Cerus USD 100.8M 12.37M Dec/2025
Charles River Laboratories USD 1.13B 41.04M Jun/2026
Danaher USD 8.1B 645M Jun/2026
Haemonetics USD 263.24M 19.36M Jun/2026
Illumina USD 1.58B 12M Jun/2026
IQVIA Holdings USD 8.82B 486M Jun/2026
Merit Medical Systems USD 264.93M 48.06M Jun/2026
Mettler Toledo International USD 1.2B 92.14M Jun/2026
Myriad Genetics USD 130.7M 500K Jun/2026
Neogen USD 158.2M 7.6M Mar/2026
OraSure Technologies USD 44.08M 4.29M Mar/2026
Pacific Biosciences Of California USD 68.81M 3.45M Jun/2026
Quidel USD 993.4M 31M Jun/2026
Revvity USD 1.28B 37.71M Jun/2026
STAAR Surgical USD 60.99M 7.51M Mar/2026
Thermo Fisher Scientific USD 15.07B 448M Jun/2026
Waters USD 2.27B 1.03B Mar/2026